Surfarray™ cell microarray technology is well suited for target deconvolution. In particular, it is used to identify primary targets for macromolecules or small molecules that exhibit the desired biological or clinical effects. It ranges from the primary goal of revealing antibodies or small molecule compounds identified by phenotypic screening to commercially available drugs. Learn more: target deconvolution strategies in drug discovery
